Pharmacokinetic study of HP-6050
Phase 1
- Conditions
- Healthy adult and elderly
- Registration Number
- JPRN-jRCT2031220536
- Lead Sponsor
- Inakura Hiroshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Healthy Japanese adults aged >=18 and <65 years, or healthy Japanese elderly aged >=65 years (at the time of informed consent)
Exclusion Criteria
- Subjects with current or history of serious cardiac, vascular, renal, hepatic, psychiatric/neurological, or metabolic diseases
- Subjects who received any drug within a week prior to application of the study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetic parameters, adverse events
- Secondary Outcome Measures
Name Time Method Pharmacodynamics